The MiSight 1 day clinical trial is one of the longest studies of soft lens myopia management conducted. Its three-part study design allows for a level of analysis unavailable in shorter, more conventional investigations. This presentation delves deeply into the data set to answer several key questions applicable to myopia management in general and MiSight 1 day in particular.
Learning Objectives:
- An understanding of how MiSight 1 day slowed the myopia of children progressing at different rates
- An understanding of how different measures can be used to fully understand treatment efficacy in myopia management
